WT p53 is required for enhanced expression of p53 target genes by BET inhibition and at least two of these genes, BBC3 and NOXA, are required for enhanced combined toxicity towards AML by dual BET and MDM2 inhibition. Here, TP53 is linked to acute myeloid leukemia.